Lineage, Inc. Common Stock (LINE)vsChiron Real Estate Inc. (XRN)
LINE
Lineage, Inc. Common Stock
$34.43
-0.03%
REAL ESTATE · Cap: $8.54B
XRN
Chiron Real Estate Inc.
$33.59
-1.50%
REAL ESTATE · Cap: $503.33M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 3402% more annual revenue ($5.37B vs $153.35M). XRN leads profitability with a 37.8% profit margin vs -3.1%. XRN earns a higher WallStSmart Score of 58/100 (C).
LINE
Avoid35
out of 100
Grade: F
XRN
Buy58
out of 100
Grade: C
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Attractively priced relative to earnings
Reasonable price relative to book value
Keeps 38 of every $100 in revenue as profit
Strong operational efficiency at 23.2%
Areas to Watch
0.8% revenue growth
0.0% earnings growth
Operating margin of 3.7%
Elevated debt levels
4.8% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : XRN
The strongest argument for XRN centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 37.8% and operating margin at 23.2%.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : XRN
The primary concerns for XRN are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while XRN is a value play — different risk/reward profiles.
XRN carries more volatility with a beta of 1.13 — expect wider price swings.
XRN is growing revenue faster at 4.8% — sustainability is the question.
LINE generates stronger free cash flow (186M), providing more financial flexibility.
Bottom Line
XRN scores higher overall (58/100 vs 35/100), backed by strong 37.8% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Chiron Real Estate Inc.
REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA
Chiron Real Estate Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?